Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus

Documenti analoghi

• Non‐linear relationship between liver fibrosis and femoral neck bone mineral density in metabolic dysfunction‐associated fatty liver disease patients with type 2 diabetes mellitus
  di: Jie Tao, et al.
  Pubblicazione: (2025)
• Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study
  di: Yoosun Cho, et al.
  Pubblicazione: (2024)
• Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis
  di: Haoyang Hu, et al.
  Pubblicazione: (2025)
• Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
  di: Iskandar Idris
  Pubblicazione: (2024)
• High estradiol/testosterone ratio increased the risk of metabolic dysfunction‐associated steatotic liver disease in men with type 2 diabetes mellitus
  di: Meng‐Han Li, et al.
  Pubblicazione: (2025)